CorMedix Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $224k
$329k +46.95%
$430k +30.51%
$283k -34.09%
$239k -15.55%
$191k -20.19%
$65k -65.74%
$2.7m +4000.19%
$43.5m +1520.98%
$311.7m +617.03%
$400.1m +28.34%
Cost of Goods and Services Sold ($367k)
$115k +131.35%
$397k +245.14%
$373k -5.94%
$205k -45.12%
$149k -27.29%
$4k -97.49%
$15.8m +424028.98%
$3.2m -79.85%
$22.1m +592.33%
$56.7m +156.55%
Gross Profit (derived) ($143k)
$214k +250.36%
$33k -84.60%
($90k) -372.54%
$34k +138.22%
$42k +22.14%
$62k +46.85%
($13.2m) -21430.10%
$40.3m +406.20%
$275.7m +584.55%
$343.4m +24.53%
Interest Income (Expense), Net $1.4m $3.8m
Research and Development Expense $15.7m $24.5m $18.8m $11.1m $13.4m $13.1m $10.7m $13.2m $3.9m $19.3m $23.4m
Selling, General and Administrative Expense $9.9m $13.9m $16.3m $20.0m $35.8m $126.4m
Amortization of Intangible Assets $156k $13.9m
Operating Lease, Expense $6k $66k $209k $208k $207k $204k
Operating Lease, Lease Income $4k
Operating Expenses $24.6m $33.1m $26.9m $20.9m $27.3m $29.5m $30.7m $49.0m $62.6m $125.6m $149.7m
Operating Income (Loss) ($24.8m)
($32.9m) -32.97%
($26.9m) +18.41%
($21.0m) +21.80%
($27.2m) -29.57%
($29.4m) -8.14%
($30.6m) -4.03%
($49.0m) -59.87%
($22.4m) +54.34%
$150.1m +771.58%
$193.7m +28.99%
Interest Income, Other $14k $326k $2.7m $3.8m
Fair Value, Option, Changes in Fair Value, Gain (Loss) $0 ($177k) $0
Foreign Currency Transaction Gain (Loss), before Tax ($8k) ($14k) ($179) ($21k) ($59k) ($21k) $37k ($29k) ($31k) ($52k)
Gain (Loss) on Investments $11k $13k $0 $268
Other Nonoperating Income (Expense) $35k $24k ($23k) $337k $2.6m
Interest Expense (non-operating) $1k $6k $2k $787k $33k $16k $27k $34k $36k $2.8m $2.8m
Other Expenses ($117k) $86k $2k
Income (Loss) from Continuing Operations before Income Taxes, Domestic $24.8m $32.9m $26.9m $21.0m $27.2m $29.4m $30.6m ($45.9m) ($19.1m) $150.0m $185.0m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $24.8m $32.9m $26.9m ($21.5m) ($27.2m) ($29.5m) ($30.3m) ($19.3m) $150.0m $185.0m
Income Tax Expense (Benefit) ($5.1m) ($5.2m) ($1.3m) ($586k) ($1.4m) ($13.0m) $4.0m
Net Income (Loss) Attributable to Parent ($24.6m)
($33.0m) -33.95%
($26.8m) +18.72%
($16.4m) +38.75%
($22.0m) -34.04%
($28.2m) -28.07%
($29.7m) -5.29%
($46.3m) -56.02%
($17.9m) +61.31%
$163.1m +1009.40%
$179.9m +10.34%
Net Income (Loss) Attributable to Noncontrolling Interest $28.2m $179.9m
Preferred Stock Dividends and Other Adjustments $0
Earnings Per Share, Basic ($0.75) ($0.74) ($0.91) ($0.30) $2.25 $2.41
Earnings Per Share, Diluted ($0.65) ($0.60) ($1.51) ($1.80) ($0.77) ($0.75) ($0.74) ($0.91) ($0.30) $2.04 $2.17
Weighted Average Number of Shares Outstanding, Basic 37.7m 40.3m 50.9m 58.9m 72k 75.6m
Weighted Average Number of Shares Outstanding, Diluted 40.3m 50.9m 58.9m 80k 86.3m
Additional Financial Items
Income (Loss) Attributable to Parent, before Tax $150.0m
Other General Expense $3.3m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $1.7m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $24.8m $32.9m $26.9m $21.0m $27.2m $29.4m $30.6m ($46.3m) $22.4m $150.1m